跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GABAPENTINA STRIDES 300 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GABAPENTINA STRIDES 300 MG CAPSULAS DURAS EFG
Approved
STANDARD
GABAPENTINA STRIDES 300 MG CAPSULAS DURAS EFG
Strides Pharma (Cyprus) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 4, 2021
Approval ID
6a803eb29edd1cb1
Company
Strides Pharma (Cyprus) Limited
Type
Standard
Approval Details
Approval Id
6a803eb29edd1cb1
Drug Cima Aemps Name
GABAPENTINA STRIDES 300 MG CAPSULAS DURAS EFG
Register Number
85699
Holder Company Name
Strides Pharma (Cyprus) Limited
Marketing Company Name
Strides Pharma (Cyprus) Limited
Holder Company Detail Path
/organization/strides-pharma-cyprus-limited
Marketing Company Detail Path
/organization/strides-pharma-cyprus-limited
Authorization Date
2021-06-04
Dosage Form
CÁPSULA DURA
Dose
300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
No
Company Name
Strides Pharma (Cyprus) Limited
Company Detail Path
/organization/strides-pharma-cyprus-limited
Company Information
Pharmaceutical Company Name
STRIDES PHARMA (CYPRUS) LIMITED
Country Name
Cyprus
City Name
nicosia,country_cy
Address
JULIA HOUSE, Themistokli Dervi
Active Ingredients
GABAPENTINA
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 4, 2021
Approval ID
6a803eb29edd1cb1
Type
Standard
Back to CIMA-AEMPS Approvals